Patent · US Active

Targeted genomic alteration

US10260062B2 · kind B2 · utility

1Cited by
27References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 24, 2011
Grant dateApr 16, 2019
Priority date
Expiry dateOct 25, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for targeted integration and/or targeted excision of one or more sequences into a cell, for example, for expression of one or more polypeptides of interest.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.